Unconventional human CD61 pairing with CD103 promotes TCR signaling and antigen-specific T cell cytotoxicity.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
01 Apr 2024
Historique:
received: 07 06 2023
accepted: 29 02 2024
medline: 2 4 2024
pubmed: 2 4 2024
entrez: 1 4 2024
Statut: aheadofprint

Résumé

Cancer remains one of the leading causes of mortality worldwide, leading to increased interest in utilizing immunotherapy strategies for better cancer treatments. In the past decade, CD103

Identifiants

pubmed: 38561495
doi: 10.1038/s41590-024-01802-3
pii: 10.1038/s41590-024-01802-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002
Organisme : Chinese Academy of Medical Sciences (CAMS)
ID : 2018-I2M-002

Informations de copyright

© 2024. The Author(s).

Références

Hynes, R. O., Ruoslahti, E. & Springer, T. A. Reflections on integrins-past, present, and future: The Albert Lasker Basic Medical Research Award. JAMA 328, 1291–1292 (2022).
pubmed: 36170060 doi: 10.1001/jama.2022.17005
Niiya, K. et al. Increased surface expression of the membrane glycoprotein IIb/IIIa complex induced by platelet activation. Relationship to the binding of fibrinogen and platelet aggregation. Blood 70, 475–483 (1987).
pubmed: 3607284 doi: 10.1182/blood.V70.2.475.475
Cepek, K. L. et al. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin. Nature 372, 190–193 (1994).
pubmed: 7969453 doi: 10.1038/372190a0
Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673–687 (2002).
pubmed: 12297042 doi: 10.1016/S0092-8674(02)00971-6
Mackay, L. K. et al. The developmental pathway for CD103
pubmed: 24162776 doi: 10.1038/ni.2744
Lefkovits, J., Plow, E. F. & Topol, E. J. Platelet glycoprotein IIb/IIIa receptors in cardiovascular medicine. N. Engl. J. Med. 332, 1553–1559 (1995).
pubmed: 7739710 doi: 10.1056/NEJM199506083322306
Gianni, T., Leoni, V., Chesnokova, L. S., Hutt-Fletcher, L. M. & Campadelli-Fiume, G. alphavbeta3-integrin is a major sensor and activator of innate immunity to herpes simplex virus-1. Proc. Natl Acad. Sci. USA 109, 19792–19797 (2012).
pubmed: 23150579 pmcid: 3511702 doi: 10.1073/pnas.1212597109
Qu, M. et al. Platelet-derived microparticles enhance megakaryocyte differentiation and platelet generation via miR-1915-3p. Nat. Commun. 11, 4964 (2020).
pubmed: 33009394 pmcid: 7532443 doi: 10.1038/s41467-020-18802-0
Moulder, K., Roberts, K., Shevach, E. M. & Coligan, J. E. The mouse vitronectin receptor is a T cell activation antigen. J. Exp. Med. 173, 343–347 (1991).
pubmed: 1703206 doi: 10.1084/jem.173.2.343
Bertoni, A., Alabiso, O., Galetto, A. S. & Baldanzi, G. Integrins in T cell physiology. Int. J. Mol. Sci. 19, 485 (2018).
pubmed: 29415483 pmcid: 5855707 doi: 10.3390/ijms19020485
Gueguen, P. et al. Contribution of resident and circulating precursors to tumor-infiltrating CD8
pubmed: 33514641 doi: 10.1126/sciimmunol.abd5778
Duhen, T. et al. Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. Nat. Commun. 9, 2724 (2018).
pubmed: 30006565 pmcid: 6045647 doi: 10.1038/s41467-018-05072-0
Yang, R. et al. Distinct epigenetic features of tumor-reactive CD8
pubmed: 31892342 pmcid: 6937914 doi: 10.1186/s13059-019-1921-y
Corgnac, S. et al. CD103
pubmed: 33205076 pmcid: 7659589 doi: 10.1016/j.xcrm.2020.100127
Abd Hamid, M. et al. Self-maintaining CD103
pubmed: 31771983 doi: 10.1158/2326-6066.CIR-19-0554
Ganesan, A. P. et al. Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer. Nat. Immunol. 18, 940–950 (2017).
pubmed: 28628092 pmcid: 6036910 doi: 10.1038/ni.3775
Malik, B. T. et al. Resident memory T cells in the skin mediate durable immunity to melanoma. Sci. Immunol. 2, eaam6346 (2017).
pubmed: 28738020 pmcid: 5525335 doi: 10.1126/sciimmunol.aam6346
Edwards, J. et al. CD103
pubmed: 29599411 doi: 10.1158/1078-0432.CCR-17-2257
Roukens, A. H. E. et al. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8
pubmed: 34937933 doi: 10.1038/s41590-021-01095-w
Williams, B. L. et al. Phosphorylation of Tyr319 in ZAP-70 is required for T-cell antigen receptor-dependent phospholipase C-gamma1 and Ras activation. EMBO J. 18, 1832–1844 (1999).
pubmed: 10202147 pmcid: 1171269 doi: 10.1093/emboj/18.7.1832
Thill, P. A., Weiss, A. & Chakraborty, A. K. Phosphorylation of a tyrosine residue on Zap70 by Lck and its subsequent binding via an SH2 domain may be a key gatekeeper of T cell receptor signaling in vivo. Mol. Cell. Biol. 36, 2396–2402 (2016).
pubmed: 27354065 pmcid: 5007795 doi: 10.1128/MCB.00165-16
George, J. et al. Comprehensive genomic profiles of small cell lung cancer. Nature 524, 47–53 (2015).
pubmed: 26168399 pmcid: 4861069 doi: 10.1038/nature14664
Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291–304 (2018).
pubmed: 29625048 pmcid: 5957518 doi: 10.1016/j.cell.2018.03.022
Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400–416 (2018).
pubmed: 29625055 pmcid: 6066282 doi: 10.1016/j.cell.2018.02.052
Sakuishi, K. et al. Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity. J. Exp. Med. 207, 2187–2194 (2010).
pubmed: 20819927 pmcid: 2947065 doi: 10.1084/jem.20100643
Thomas, S. et al. Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen. Blood 118, 319–329 (2011).
pubmed: 21606483 doi: 10.1182/blood-2010-12-326736
Abd Hamid, M. et al. Defective interferon gamma production by tumor-specific CD8
pubmed: 32194559 pmcid: 7066077 doi: 10.3389/fimmu.2020.00310
Li, X. et al. A comprehensive analysis of key immune checkpoint receptors on tumor-infiltrating T cells from multiple types of cancer. Front. Oncol. 9, 1066 (2019).
pubmed: 31709176 pmcid: 6823747 doi: 10.3389/fonc.2019.01066
Riley, J. L. PD-1 signaling in primary T cells. Immunol. Rev. 229, 114–125 (2009).
pubmed: 19426218 pmcid: 3424066 doi: 10.1111/j.1600-065X.2009.00767.x
Ahn, E. et al. Role of PD-1 during effector CD8 T cell differentiation. Proc. Natl Acad. Sci. USA 115, 4749–4754 (2018).
pubmed: 29654146 pmcid: 5939075 doi: 10.1073/pnas.1718217115
Pauls, K. et al. Role of integrin alphaE(CD103)beta7 for tissue-specific epidermal localization of CD8
pubmed: 11564161 doi: 10.1046/j.0022-202x.2001.01481.x
Somersalo, K. et al. Cytotoxic T lymphocytes form an antigen-independent ring junction. J. Clin. Invest. 113, 49–57 (2004).
pubmed: 14702108 pmcid: 300769 doi: 10.1172/JCI19337
Franciszkiewicz, K. et al. CD103 or LFA-1 engagement at the immune synapse between cytotoxic T cells and tumor cells promotes maturation and regulates T-cell effector functions. Cancer Res. 73, 617–628 (2013).
pubmed: 23188505 doi: 10.1158/0008-5472.CAN-12-2569
Ling, K. L. et al. Modulation of CD103 expression on human colon carcinoma-specific CTL. J. Immunol. 178, 2908–2915 (2007).
pubmed: 17312135 doi: 10.4049/jimmunol.178.5.2908
Yu, C. I. et al. Human CD1c
pubmed: 23562160 pmcid: 3639491 doi: 10.1016/j.immuni.2013.03.004
Pallett, L. J. et al. IL-2
pubmed: 28526759 pmcid: 5461007 doi: 10.1084/jem.20162115
Wu, C. H. et al. Ni-induced TGF-beta signaling promotes VEGF-a secretion via integrin beta3 upregulation. J. Cell. Physiol. 234, 22093–22102 (2019).
pubmed: 31066035 doi: 10.1002/jcp.28772
Monks, C. R., Freiberg, B. A., Kupfer, H., Sciaky, N. & Kupfer, A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395, 82–86 (1998).
pubmed: 9738502 doi: 10.1038/25764
Stinchcombe, J. C., Bossi, G., Booth, S. & Griffiths, G. M. The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 15, 751–761 (2001).
pubmed: 11728337 doi: 10.1016/S1074-7613(01)00234-5
Tseng, S. Y., Waite, J. C., Liu, M., Vardhana, S. & Dustin, M. L. T cell-dendritic cell immunological synapses contain TCR-dependent CD28-CD80 clusters that recruit protein kinase C theta. J. Immunol. 181, 4852–4863 (2008).
pubmed: 18802089 doi: 10.4049/jimmunol.181.7.4852
Jenkins, M. R., Tsun, A., Stinchcombe, J. C. & Griffiths, G. M. The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse. Immunity 31, 621–631 (2009).
pubmed: 19833087 pmcid: 2791175 doi: 10.1016/j.immuni.2009.08.024
Dustin, M. L., Chakraborty, A. K. & Shaw, A. S. Understanding the structure and function of the immunological synapse. Cold Spring Harb. Perspect. Biol. 2, a002311 (2010).
pubmed: 20843980 pmcid: 2944359 doi: 10.1101/cshperspect.a002311
Dustin, M. L., Bromley, S. K., Kan, Z., Peterson, D. A. & Unanue, E. R. Antigen receptor engagement delivers a stop signal to migrating T lymphocytes. Proc. Natl Acad. Sci. USA 94, 3909–3913 (1997).
pubmed: 9108078 pmcid: 20541 doi: 10.1073/pnas.94.8.3909
Grakoui, A. et al. The immunological synapse: a molecular machine controlling T cell activation. Science 285, 221–227 (1999).
pubmed: 10398592 doi: 10.1126/science.285.5425.221
Carrasco, Y. R., Fleire, S. J., Cameron, T., Dustin, M. L. & Batista, F. D. LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation. Immunity 20, 589–599 (2004).
pubmed: 15142527 doi: 10.1016/S1074-7613(04)00105-0
Stinchcombe, J. C., Majorovits, E., Bossi, G., Fuller, S. & Griffiths, G. M. Centrosome polarization delivers secretory granules to the immunological synapse. Nature 443, 462–465 (2006).
pubmed: 17006514 doi: 10.1038/nature05071
Scholer, A., Hugues, S., Boissonnas, A., Fetler, L. & Amigorena, S. Intercellular adhesion molecule-1-dependent stable interactions between T cells and dendritic cells determine CD8
pubmed: 18275834 doi: 10.1016/j.immuni.2007.12.016
Reddy, K. B., Smith, D. M. & Plow, E. F. Analysis of Fyn function in hemostasis and alphaIIbbeta3-integrin signaling. J. Cell Sci. 121, 1641–1648 (2008).
pubmed: 18430780 doi: 10.1242/jcs.014076
Sun, G., Guillon, E. & Holley, S. A. Integrin intra-heterodimer affinity inversely correlates with integrin activatability. Cell Rep. 35, 109230 (2021).
pubmed: 34107244 pmcid: 8227800 doi: 10.1016/j.celrep.2021.109230
Fuentes, P. et al. ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells. Nat. Commun. 11, 4261 (2020).
pubmed: 32848136 pmcid: 7450082 doi: 10.1038/s41467-020-18081-9
Chen, J. L. et al. NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus. Int J. Cancer 136, E590–E601 (2015).
pubmed: 25081390 doi: 10.1002/ijc.29118
Nasulewicz-Goldeman, A., Uszczynska, B., Szczaurska-Nowak, K. & Wietrzyk, J. siRNA-mediated silencing of integrin beta3 expression inhibits the metastatic potential of B16 melanoma cells. Oncol. Rep. 28, 1567–1573 (2012).
pubmed: 22895695 pmcid: 3583467 doi: 10.3892/or.2012.1963
Prota, G. et al. Enhanced immunogenicity of mitochondrial-localized proteins in cancer cells. Cancer Immunol. Res 8, 685–697 (2020).
pubmed: 32205315 doi: 10.1158/2326-6066.CIR-19-0467
Schober, K. et al. Orthotopic replacement of T-cell receptor alpha- and beta-chains with preservation of near-physiological T-cell function. Nat. Biomed. Eng. 3, 974–984 (2019).
pubmed: 31182835 doi: 10.1038/s41551-019-0409-0
Muntel, J. et al. Comparison of protein quantification in a complex background by DIA and TMT workflows with fixed instrument time. J. Proteome Res. 18, 1340–1351 (2019).
pubmed: 30726097 doi: 10.1021/acs.jproteome.8b00898
O'Brien, D. P. et al. Structural premise of selective deubiquitinase USP30 inhibition by small-molecule benzosulfonamides. Mol. Cell Proteom. 22, 100609 (2023).
doi: 10.1016/j.mcpro.2023.100609
Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284–287 (2012).
pubmed: 22455463 pmcid: 3339379 doi: 10.1089/omi.2011.0118
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
pubmed: 34557778 pmcid: 8454663
Yu, G. & He, Q. Y. ReactomePA: an R/Bioconductor package for reactome pathway analysis and visualization. Mol. Biosyst. 12, 477–479 (2016).
pubmed: 26661513 doi: 10.1039/C5MB00663E
Cespedes, P. F. & Dustin, M. L. Preparation of bead-supported lipid bilayers to study the particulate output of T cell immune synapses. J. Vis. Exp. https://doi.org/10.3791/63130 (2022).
Cespedes, P. F. et al. T-cell trans-synaptic vesicles are distinct and carry greater effector content than constitutive extracellular vesicles. Nat. Commun. 13, 3460 (2022).
pubmed: 35710644 pmcid: 9203538 doi: 10.1038/s41467-022-31160-3
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
pubmed: 22743772 doi: 10.1038/nmeth.2019
Stauffer, W., Sheng, H. & Lim, H. N. EzColocalization: an ImageJ plugin for visualizing and measuring colocalization in cells and organisms. Sci. Rep. 8, 15764 (2018).
pubmed: 30361629 pmcid: 6202351 doi: 10.1038/s41598-018-33592-8
Varma, R., Campi, G., Yokosuka, T., Saito, T. & Dustin, M. L. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity 25, 117–127 (2006).
pubmed: 16860761 pmcid: 1626533 doi: 10.1016/j.immuni.2006.04.010
Choudhuri, K. et al. Polarized release of T-cell-receptor-enriched microvesicles at the immunological synapse. Nature 507, 118–123 (2014).
pubmed: 24487619 pmcid: 3949170 doi: 10.1038/nature12951
Saliba, D. G. et al. Composition and structure of synaptic ectosomes exporting antigen receptor linked to functional CD40 ligand from helper T cells. Elife https://doi.org/10.7554/eLife.47528 (2019).
Shenderov, E. et al. Generation and characterization of HLA-A2 transgenic mice expressing the human TCR 1G4 specific for the HLA-A2 restricted NY-ESO-1(157-165) tumor-specific peptide. J. Immunother. Cancer 9, e002544 (2021).
pubmed: 34088742 pmcid: 8183295 doi: 10.1136/jitc-2021-002544
Kosinski, M. RTCGA: TCGA data integration. R package version 1.24.0. https://rtcga.github.io/RTCGA/ (2021).
Cerami, E. et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401–404 (2012).
pubmed: 22588877 doi: 10.1158/2159-8290.CD-12-0095
Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal 6, pl1 (2013).
pubmed: 23550210 pmcid: 4160307 doi: 10.1126/scisignal.2004088
Ellrott, K. et al. Scalable open science approach for mutation calling of tumor exomes using multiple genomic pipelines. Cell Syst. 6, 271–281 (2018).
pubmed: 29596782 pmcid: 6075717 doi: 10.1016/j.cels.2018.03.002
Taylor, A. M. et al. Genomic and functional approaches to understanding cancer aneuploidy. Cancer Cell 33, 676–689 (2018).
pubmed: 29622463 pmcid: 6028190 doi: 10.1016/j.ccell.2018.03.007
Therneau, T. A package for survival analysis in R. R package version 3.2-13. https://CRAN.R-project.org/package=survival (2021).
Hamid, A. et al. An unconventional integrin 3 and CD103 heterodimer improves the anti-tumor immunity of tissue-resident T cells. Mendeley Data, v1.10.17632/b2xdk4h5xm.1s (2021).

Auteurs

Megat H B A Hamid (MHBA)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Pablo F Cespedes (PF)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.

Chen Jin (C)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Department of Cardiothoracic Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Ji-Li Chen (JL)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
MRC Translational Immune Discovery Unity, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Uzi Gileadi (U)

MRC Translational Immune Discovery Unity, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Elie Antoun (E)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Zhu Liang (Z)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Target Discovery Institute, Centre for Medicines Discovery, University of Oxford, Oxford, UK.

Fei Gao (F)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Renuka Teague (R)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.

Nikita Manoharan (N)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

David Maldonado-Perez (D)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.

Nasullah Khalid-Alham (N)

Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK.
Oxford National Institute of Health Research (NIHR) Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.

Lucia Cerundolo (L)

Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.

Raul Ciaoca (R)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Svenja S Hester (SS)

Target Discovery Institute, Centre for Medicines Discovery, University of Oxford, Oxford, UK.

Adán Pinto-Fernández (A)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Target Discovery Institute, Centre for Medicines Discovery, University of Oxford, Oxford, UK.

Simeon D Draganov (SD)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Target Discovery Institute, Centre for Medicines Discovery, University of Oxford, Oxford, UK.

Iolanda Vendrell (I)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Target Discovery Institute, Centre for Medicines Discovery, University of Oxford, Oxford, UK.

Guihai Liu (G)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Xuan Yao (X)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Audun Kvalvaag (A)

Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.
Department of Molecular Cell Biology, Institute of Cancer Research, Oslo University Hospital, Oslo, Norway.

Delaney C C Dominey-Foy (DCC)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Charunya Nanayakkara (C)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Nikolaos Kanellakis (N)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Oxford National Institute of Health Research (NIHR) Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals, Oxford, UK.

Yi-Ling Chen (YL)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
MRC Translational Immune Discovery Unity, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Craig Waugh (C)

Flow Cytometry Facility, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Sally-Ann Clark (SA)

Flow Cytometry Facility, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Kevin Clark (K)

Flow Cytometry Facility, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Paul Sopp (P)

Flow Cytometry Facility, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Najib M Rahman (NM)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Oxford National Institute of Health Research (NIHR) Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.
Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals, Oxford, UK.

Clare Verrill (C)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Oxford National Institute of Health Research (NIHR) Biomedical Research Centre, John Radcliffe Hospital, Oxford, UK.

Benedikt M Kessler (BM)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Target Discovery Institute, Centre for Medicines Discovery, University of Oxford, Oxford, UK.

Graham Ogg (G)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
MRC Translational Immune Discovery Unity, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Ricardo A Fernandes (RA)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.

Roman Fisher (R)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Target Discovery Institute, Centre for Medicines Discovery, University of Oxford, Oxford, UK.

Yanchun Peng (Y)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
MRC Translational Immune Discovery Unity, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.

Michael L Dustin (ML)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK.

Tao Dong (T)

CAMS Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK. tao.dong@ndm.ox.ac.uk.
MRC Translational Immune Discovery Unity, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. tao.dong@ndm.ox.ac.uk.

Classifications MeSH